Suchergebnisse - "Chen, Jingde"

PubPharm (64)

21

High-Light-Tolerance PbI2 Boosting the Stability and Efficiency of Perovskite Solar Cells

enthalten in: ACS applied materials & interfaces | 2021

von Chen, L. | Chen, J. | Wang, C. | +7

22

CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine-induced STAT3 activation

enthalten in: Journal of cellular and molecular medicine | 2021

von Yu, S. | Chen, J. | Quan, M. | +3

23

CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine‐induced STAT3 activation

enthalten in: Journal of Cellular and Molecular Medicine | 2021

von Yu, S. | Chen, J. | Quan, M. | +3

24

Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high : an open-label prospective pivotal trial

enthalten in: Journal of cancer research and clinical oncology | 2020

von Chen, J. | Quan, M. | Chen, Z. | +5

25

Hierarchically Manipulated Charge Recombination for Mitigating Energy Loss in CsPbI2Br Solar Cells

enthalten in: ACS applied materials & interfaces | 2020

von Luo, Y. | Chen, J. | Hou, H. | +7

26

RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer

enthalten in: Medical oncology (Northwood, London, England) | 2020

von Yang, H. | Hu, J. | Chen, J. | +5

27

RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer

enthalten in: Medical oncology | 2020

von Yang, H. | Hu, J. | Chen, J. | +5

28

RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer

enthalten in: Medical oncology | 2020

von Yang, H. | Hu, J. | Chen, J. | +5

29

Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial

enthalten in: Journal of cancer research and clinical oncology | 2020

von Chen, J. | Quan, M. | Chen, Z. | +5

30

Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial

enthalten in: Journal of cancer research and clinical oncology | 2020

von Chen, J. | Quan, M. | Chen, Z. | +5